Inflammatory bowel disease: clinical aspects and established and evolving therapies
about
Crohn's disease and early exposure to domestic refrigerationOral budesonide for induction of remission in ulcerative colitisEndoscopic scoring indices for evaluation of disease activity in ulcerative colitisBudesonide for induction of remission in Crohn's diseaseBudesonide for maintenance of remission in Crohn's diseaseHistologic scoring indices for evaluation of disease activity in ulcerative colitisLow dose naltrexone for induction of remission in Crohn's diseaseLow dose naltrexone for induction of remission in Crohn's diseaseOral budesonide for induction of remission in ulcerative colitisProbiotics for patients with hepatic encephalopathyBudesonide for maintenance of remission in Crohn's diseaseTacrolimus (FK506) for induction of remission in refractory ulcerative colitisBudesonide for induction of remission in Crohn's diseaseTraditional corticosteroids for induction of remission in Crohn's diseaseRole of the gut microbiota in defining human healthUstekinumabPotential Benefits of Dietary Fibre Intervention in Inflammatory Bowel DiseaseHydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing associationFlavonoids in Inflammatory Bowel Disease: A ReviewIndirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic reviewMinimally invasive surgery for inflammatory bowel disease: Review of current developments and future perspectivesPart 1: The Human Gut Microbiome in Health and DiseaseRole of antibiotics for treatment of inflammatory bowel diseaseLymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disordersStructural brain lesions in inflammatory bowel diseaseThe Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An UpdateEndoscopic Therapy in Inflammatory Bowel DiseasesEosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic InfectionsMucosal resident memory CD4 T cells in protection and immunopathologyUlcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrierThe role of physical exercise in inflammatory bowel diseaseInterleukin-23: as a drug target for autoimmune inflammatory diseasesThe dopaminergic system in autoimmune diseasesRole of commensal gut bacteria in inflammatory bowel diseasesNeuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-PigsA low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel diseaseDissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal ModelsEfficacy and safety of antiintegrin antibody for inflammatory bowel disease: a systematic review and meta-analysisOsteopontin expression by CD103- dendritic cells drives intestinal inflammationEvaluation and characterization of bacterial metabolic dynamics with a novel profiling technique, real-time metabolotyping
P2860
Q21092151-F1AE412F-AED9-4AD8-AEAA-02EB3618E5A8Q24186368-9D152FED-9E8E-4EDB-A59E-FE043D0BF7E3Q24187044-D731D9E9-0A03-4068-9D17-3CF5B487667BQ24187309-5651C63E-30C1-46E2-B097-267975C23578Q24194313-B0BFF063-8CDD-42A6-BCD9-EA8E0D36AA80Q24194674-E858F39A-9962-4662-873F-556A79D17757Q24200319-5040A7BB-C849-472C-9437-3F65B91DC29DQ24201218-A33F4F05-DA80-4281-88EB-C87EB770898EQ24234633-68F1E88C-1759-4891-A188-2312D02A91F4Q24235259-7E751987-5B3B-437D-8884-C67215152D8CQ24241252-3E183352-1194-444C-BD63-0CFB6C92A4BCQ24242681-5019FEEC-C523-4C9F-BD4D-170DE7D04231Q24242729-E1568F73-C46C-4C12-908C-9E187A637DECQ24242955-19A9EE97-9214-4D8A-85EF-AB2D5ABA7769Q24599062-058F703F-98F8-4534-8384-E8352980C900Q24651927-5F7B8A67-7B0C-4484-B50A-467C99FC1921Q26744514-0AA65FDD-82DB-4574-A314-AF3A2396EE0AQ26745455-35B95BAC-46FE-409A-9984-8BFA614E5249Q26748883-8D9CA8A2-DFA9-44DE-8968-D4CC487DA458Q26749259-52726FBB-5FA4-4B8C-B8CD-77823A50FBA9Q26751161-006E3E9A-6B92-446B-B042-8DA298B3B06FQ26771948-65CEB020-992E-4DF7-9C60-8F38BC99E8D6Q26774552-4CF039BA-3172-45BC-90BE-5E8897B6955FQ26776151-268F3AD0-AE46-4619-9634-CB35968B8596Q26776172-0AC5DAED-D7A6-4CA0-AB62-AA9444196C6BQ26777192-0E9E2A3E-17BE-4118-893E-125327A825A4Q26777718-835BD958-614A-4A6E-844C-C1AE50BEAC01Q26799615-4062023F-D5FC-49D1-9326-4CFB10CD063FQ26823137-DF657462-48B6-4925-A44D-85A1CC72C2A3Q26825483-B0DFCFD1-6B7E-41FD-9B1F-CFAB4082031CQ26865777-201F5464-7276-44B9-BF51-6D80F04FFB2CQ27009502-B1F546EC-F333-4E23-9858-BE88AB559958Q27023885-79FABD03-2B0A-4ECF-9F68-05C2F7F8F7A2Q27024137-6D4AB101-8F91-4414-BE2F-F14AB4B032C8Q27316366-A02148CF-AB60-46FB-A653-3B021D1A37C5Q27335631-24AB8AC3-127C-43C7-9E48-9D0754AF491DQ28072332-7D309B7C-2D3D-47D9-AB8C-5E3792E27C71Q28084236-823AD334-D953-45E5-8700-8F3CEAC0764FQ28307824-A959352E-DA41-4880-8678-3DC893F1319BQ28475065-F02C5B58-0604-4361-A21C-D992ADBCBF16
P2860
Inflammatory bowel disease: clinical aspects and established and evolving therapies
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@ast
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@en
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@en-gb
type
label
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@ast
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@en
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@en-gb
prefLabel
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@ast
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@en
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@en-gb
P3181
P1433
P1476
Inflammatory bowel disease: clinical aspects and established and evolving therapies
@en
P2093
Daniel C Baumgart
P304
P3181
P356
10.1016/S0140-6736(07)60751-X
P407
P577
2007-05-01T00:00:00Z